Search Results 171-180 of 45082 for Two-phase

  1. Phase 2 Placebo-Controlled, Double-Blind, Multicenter Study To Evaluate The Efficacy, Safety, And Tolerability Of DCR-PHXC Solution For Injection (Subcutaneous Use) In Patients With Primary Hyperoxaluria - PHYOX 2 - Mayo Clinic

    Phase 2 Placebo-Controlled, Double-Blind, Multicenter Study To Evaluate The Efficacy, Safety, And Tolerability Of DCR-PHXC Solution For Injection (Subcutaneous ...

  2. A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  3. Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA - Mayo Clinic

    Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA · Overview · Participation eligibility · Participating Mayo Clinic ...

  4. Study To Evaluate The Safety, Phage Kinetics, And Efficacy Of Inhaled AP-PA02 In Subjects With Non-Cystic Fibrosis Bronchiectasis And Chronic Pulmonary Pseudomonas Aeruginosa Infection (Tailwind) - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  5. Infant formula: 7 steps to prepare it safely - Mayo Clinic

    You might continue sanitizing bottles daily if your baby: Is younger than 2 months. Was born prematurely. Has a weakened immune system. 4.

  6. A Phase 2, Multicenter, Study Of Ficlatuzumab Plus Erlotinib Versus Placebo Plus Erlotinib In Subjects Who Have Previously Untreated Metastatic, EGFR-mutated Non-small Cell Lung Cancer (NSCLC) And BDX004 Positive Label - Mayo Clinic

    A Phase 2, Multicenter, Study Of Ficlatuzumab Plus Erlotinib Versus Placebo Plus Erlotinib In Subjects Who Have Previously Untreated Metastatic, ...

  7. A Phase 2 Study To Assess The Safety And Efficacy Of Intravitreal ONL1204 Ophthalmic Solution In Subjects With Mac-off Retinal Detachment - Mayo Clinic

    A Phase 2 Study To Assess The Safety And Efficacy Of Intravitreal ONL1204 Ophthalmic Solution In Subjects With Mac-off Retinal Detachment · Share · Facebook ...

  8. LEAP 2 Chronic EFS - Mayo Clinic

    In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new ...

  9. Neurology - Clinical trials - Mayo Clinic

    To accomplish this aim CREST-H will add on to the NINDS-sponsored CREST-2 trial (parallel, outcome-blinded Phase ... stage (PAF), and even at a prodromal stage ( ...

  10. A Phase 1/2 Trial of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 as Neoadjuvant Chemotherapy in Locally Advanced, Unresectable Pancreatic Cancer - Mayo Clinic

    A Phase 1/2 Trial of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 as Neoadjuvant Chemotherapy in Locally Advanced, Unresectable Pancreatic Cancer.